Clinical Research Directory
Browse clinical research sites, groups, and studies.
Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Sponsor: Rongrong Zhou
Summary
The goal of this clinical trial is to learn if hypofractionated radiotherapy works to shorten the treatment time without increasing the side effects in patients of thymic epithelial tumors. The main questions it aims to answer are: * Does Hypofractionated radiotherapy provide better results? * Can hypofractionated radiotherapy reduce toxic and side effects compared with conventional radiotherapy? Researchers will compare the efficacy and safety of hypofractionated radiotherapy after thymic tumor surgery. Participants will: * Receive hypofractionated radiotherapy or conventional radiotherapy * Visit the hospital regularly once every 12 weeks for checkups and tests
Official title: A Prospective Study of Hypofractionated Radiotherapy for Thymic Epithelial Tumors
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
100
Start Date
2024-10-01
Completion Date
2027-11-01
Last Updated
2024-11-18
Healthy Volunteers
No
Interventions
Hypofractionated Radiation Therapy
R0 resection: 45-50Gy/20-25f R1 resection: 54-56Gy/25-28f R2 resection: 60-70Gy/30-35f
Locations (1)
Xiangya Hospital, Central South University
Changsha, Hunan, China